Table 1.
Demographics and clinicopathologic characteristics of samples from patients with NSCLC.
| Characteristics | n = 79 |
|---|---|
| Age,M±SD(IQR), years | 57±10 (50-66) |
| Sex, n (%) | |
| Male | 35(44.3%) |
| Female | 44(55.7%) |
| Tumor diameter, n (%) | |
| ≤2 cm | 62(78.5%) |
| >2 cm | 17(21.5%) |
| TNM stage, n (%) | |
| IA | 56(70.9%) |
| IB | 23(29.1%) |
| Presence of lymph node metastasis, n (%) | |
| Metastasis | 6(7.6%) |
| No Metastasis | 73(92.4%) |
| CEA,M(IQR) | 2.58 (1.34-3) |
| Cyfra21.1,M(IQR) | 2.11(1.44-2.52) |
NSCLC, non-small cell lung cancer; TNM, tumor node metastasis; CEA, carcinoembryonic antigen.